(Columbus, Ohio) – Ohio Attorney General Mike DeWine, along with 37 other state attorneys general, announced today a $40.75 million settlement, pending court approval, with pharmaceutical companies GlaxoSmithKline, LLC (GSK) and SB Pharmco Puerto Rico, Inc. (SB Pharmco) to resolve concerns about their alleged substandard manufacturing processes.
In a complaint filed today, Attorney General DeWine alleged that GSK and SB Pharmco engaged in unfair and deceptive practices when they manufactured and distributed batches of certain prescription drugs from a facility in Cidra, Puerto Rico from 2001 to 2004. The manufacturing processes used to produce the batches were substandard.